# Fresenius Medical Care AG: Form 20-F for the period ended Dec 31, 2011

- Company: [Fresenius Medical Care AG](/companies/fms.md) (CIK 1333141)
- Form: 20-F
- Filed: 2012-02-23
- Accepted by EDGAR: Feb 23, 2012, 16:23 ET
- Period: 2011-12-31
- Accession: 0000950123-12-002984
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1333141/000095012312002984/f03943e20vf.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1333141/000095012312002984/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 12 months, 2011-01-01 to 2011-12-31 | $8.27bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2011-01-01 to 2011-12-31 | $4.52bn | us-gaap:GrossProfit |
| Research and development | 12 months, 2011-01-01 to 2011-12-31 | $110.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2011-01-01 to 2011-12-31 | $2.37bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2011-01-01 to 2011-12-31 | $2.07bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2011-01-01 to 2011-12-31 | $356.4m | us-gaap:InterestExpense |
| Income tax | 12 months, 2011-01-01 to 2011-12-31 | $601.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2011-01-01 to 2011-12-31 | $1.07bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2011-01-01 to 2011-12-31 | $3.51 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2011-01-01 to 2011-12-31 | $3.54 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2011-01-01 to 2011-12-31 | 300,808,487 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2011-01-01 to 2011-12-31 | $1.45bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2011-01-01 to 2011-12-31 | $597.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2011-01-01 to 2011-12-31 | $280.6m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | at 2011-12-31 | $457.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2011-12-31 | $5.70bn | us-gaap:AssetsCurrent |
| Total assets | at 2011-12-31 | $19.53bn | us-gaap:Assets |
| Current liabilities | at 2011-12-31 | $4.26bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2011-12-31 | $11.06bn | us-gaap:Liabilities |
| Long-term debt | at 2011-12-31 | $5.49bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2011-12-31 | $126.8m | us-gaap:DebtCurrent |
| Short-term borrowings | at 2011-12-31 | $98.8m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2011-12-31 | $7.90bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2011-12-31 | 300,164,922 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1333141/000095012312002984/f03943e20vf.htm

Filed Feb 23, 2012.
Source: SEC EDGAR, the filing index for accession 0000950123-12-002984. Last ingested by Listed: Nov 14, 2026, 17:40 ET. No prices; not investment advice.
